Medical Condition News

RSS

Aquaporin 5 induction may be a potential therapy to accelerate resurfacing of corneal defects

Corneal defects often heal themselves, but serious injuries that are left untreated can result in inflammation, infection, ulceration and even blindness.

30 Sep 2021

Research points to new opportunities to prevent treatment resistance in fragile X syndrome

Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder - fragile X syndrome - might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.

29 Sep 2021

New 'priming' approach may improve the efficacy of chemotherapy for pancreatic cancer

A new approach to 'prime' the tumor environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer.

29 Sep 2021

UTA researcher studying how TBI affects communication between neural cells

A University of Texas at Arlington researcher is studying how traumatic brain injuries (TBI) affect the ability of neural cells and surrounding cells to communicate with each other.

29 Sep 2021

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Researchers explore the germinal cell responses in both healthy individuals and kidney transplant patients in their recent study.

29 Sep 2021

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

In the current study, researchers investigate the transplacental transmission of antibodies in vaccinated pregnant women.

29 Sep 2021

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Rethinking what causes pain and how great of a threat it is can provide chronic pain patients with lasting relief and alter brain networks associated with pain processing, according to new University of Colorado Boulder-led research.

29 Sep 2021

Study investigates the mechanism underlying kidney damage in COVID-19 patients

A review article published in the journal Frontiers in Physiology by researchers affiliated with the Federal University of São Paulo in Brazil discusses the mechanisms whereby SARS-CoV-2 damages the kidneys, potentially serving as a basis for further research in pursuit of treatments to prevent severe renal problems and even chronic kidney disease in COVID-19 patients.

29 Sep 2021

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for breast cancer patients when diagnostic dilemmas arise.

29 Sep 2021

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

The Patient-Centered Outcomes Research Institute Board of Governors today approved $61.3 million for a slate of several infrastructure projects that will support the activities of eight Clinical Research Networks to implement the next phase of PCORnet, the National Patient-Centered Clinical Research Network.

29 Sep 2021

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Buck Institute professors Judith Campisi, PhD and Lisa Ellerby PhD, have been awarded a $14.3 million grant from the NIH's National Institute of Aging to study cellular senescence, one of the major hallmarks of aging, as a driver of Alzheimer's disease and other age-related dementias.

29 Sep 2021

Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate

Patients with excited delirium who are combative, aggressive or agitated before being transported to the hospital or in an emergency department setting require immediate treatment for their safety and others.

29 Sep 2021

Understanding noise-related hearing loss through changes in RNA levels

A growing number of people are suffering from hearing loss due to exposure to loud noises from heavy machinery, concerts, or explosions.

29 Sep 2021

Long-held theory of cancer-induced immune suppression requires revision, study says

Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism operates requires revision, according to a study published in Clinical Cancer Research.

29 Sep 2021

People with asymmetric brain arteries have a higher risk of developing aneurysms

It's called a silent killer. Warnings are rare, but of the million people who suffer a ruptured brain aneurysm each year, almost half will die and only a third will recover without disabilities.

29 Sep 2021

Study finds decline in referrals and procedures for common cardiac interventions after COVID-19

An analysis of healthcare data in Ontario, Canada found a significant decline in referrals and procedures performed for common cardiac interventions after the onset of the COVID-19 pandemic.

29 Sep 2021

Scientists link insulin resistance to increased risk of developing major depressive disorder

Stanford Medicine scientists have linked insulin resistance to an increased risk of developing a major depressive disorder.

29 Sep 2021

Bipolar disorder patients experiencing manic episodes likely to show abnormal brain changes

Patients with bipolar disorder who experience manic episodes are more likely to show abnormal brain changes over time, according to one of the largest longitudinal brain imaging studies in its field to date.

29 Sep 2021

Artificial intelligence tool to predict the risk of psychotic illness

One-third of children with a microdeletion of chromosome 22 will later develop a psychotic illness such as schizophrenia. But how do we know which of these children might be affected? Today, various studies have contributed to the understanding of the neurobiological mechanisms that are associated with the development of psychotic illnesses.

29 Sep 2021

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.

29 Sep 2021

Medical Condition News

Aquaporin 5 induction may be a potential therapy to accelerate resurfacing of corneal defects

Research points to new opportunities to prevent treatment resistance in fragile X syndrome

New 'priming' approach may improve the efficacy of chemotherapy for pancreatic cancer

UTA researcher studying how TBI affects communication between neural cells

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Study investigates the mechanism underlying kidney damage in COVID-19 patients

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate

Understanding noise-related hearing loss through changes in RNA levels

Long-held theory of cancer-induced immune suppression requires revision, study says

People with asymmetric brain arteries have a higher risk of developing aneurysms

Study finds decline in referrals and procedures for common cardiac interventions after COVID-19

Scientists link insulin resistance to increased risk of developing major depressive disorder

Bipolar disorder patients experiencing manic episodes likely to show abnormal brain changes

Artificial intelligence tool to predict the risk of psychotic illness

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News